Literature DB >> 28461659

Direct and Indirect Cell-Based Enzyme-Linked Immunosorbent Assay.

Thomas O Kohl, Carl A Ascoli.   

Abstract

The direct cell-based enzyme-linked immunosorbent assay (ELISA) has developed into a popular alternative immunoassay for the rapid detection of expressed cell-surface antigens or receptors. It is used to determine cell surface antigen expression profiles using existing reporter-labeled antibodies. The target specificity of newly developed antibodies can be determined by the indirect approach, which screens hybridoma supernatants for antibody reactivity against the target antigen of interest. The cell-based ELISA acts as a surrogate for the identification of immunohistochemistry-reactive (IHC) antibodies and aids in hybridoma-derived antibody identification, which is used for further ELISA development. Briefly, cells are adsorbed onto the microtiter plate surface and then fixed. Next, either hybridoma supernatant or reporter-labeled antibody is added and allowed to bind, followed by a washing step to remove unbound antibodies. For the indirect approach-during the screening of hybridoma supernatant-a reporter-labeled species-specific secondary antibody is added. For either approach, the next step is the addition of substrate. Substrate hydrolysis is proportional to the level of cell-surface antigen expression and can be measured using a microplate reader. Cell-based ELISAs have detection sensitivities comparable to quantitative analyses by flow cytometry and can be developed in multiplex format using different reporters for the analysis of cell populations.
© 2017 Cold Spring Harbor Laboratory Press.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28461659     DOI: 10.1101/pdb.prot093732

Source DB:  PubMed          Journal:  Cold Spring Harb Protoc        ISSN: 1559-6095


  3 in total

1.  Cross-Reactive Bactericidal Antimeningococcal Antibodies Can Be Isolated From Convalescing Invasive Meningococcal Disease Patients Using Reverse Vaccinology 2.0.

Authors:  Fadil A Bidmos; Simon Nadel; Gavin R Screaton; J Simon Kroll; Paul R Langford
Journal:  Front Immunol       Date:  2018-07-16       Impact factor: 7.561

2.  Bronchial epithelium repair by Esculentin-1a-derived antimicrobial peptides: involvement of metalloproteinase-9 and interleukin-8, and evaluation of peptides' immunogenicity.

Authors:  Floriana Cappiello; Danilo Ranieri; Veronica Carnicelli; Bruno Casciaro; Han-Tang Chen; Loretta Ferrera; Y Peter Di; Maria Luisa Mangoni
Journal:  Sci Rep       Date:  2019-12-12       Impact factor: 4.379

3.  4H12, a Murine Monoclonal Antibody Directed against Myosin Heavy Chain-9 Expressed on Acinar Cell Carcinoma of Pancreas with Potential Therapeutic Application

Authors:  Sima Balouchi-Anaraki; Simin Ahmadvand; Akbar Safaei; Abbas Ghaderi
Journal:  Iran Biomed J       Date:  2021-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.